-
Pyridostigmine and Placental Necroptosis in Preeclampsia
2026-08-19
The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and shows that pyridostigmine improves disease-associated outcomes in a reduced uterine perfusion pressure rat model. Pharmacological reversal by α-bungarotoxin links these effects to α7 nicotinic acetylcholine receptor signaling and provides a mechanistic framework for studying non-neuronal cholinergic regulation of placental injury.
-
Measuring Drug Response Beyond Cell Viability
2026-08-18
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability to clarify how cancer drugs combine growth inhibition and cell killing. Its central implication is practical: drug-response studies should measure proliferation and death as related but noninterchangeable outcomes, ideally with attention to their different timing.
-
USP36–Snail1 Control of Ribotoxic Stress in Cancer
2026-08-18
The reference study identifies a noncanonical nucleolar function for Snail1: after ribotoxic stress, JNK-driven USP36 induction stabilizes nucleolar Snail1, supporting ribosome biogenesis and cancer-cell survival. This mechanism helps explain why homoharringtonine is active in leukemia but relatively ineffective against solid tumors, and it provides a rationale for combination strategies that disrupt the JNK–USP36–Snail1 axis.
-
Aclacinomycin A for DNA Damage Workflows
2026-08-17
Aclacinomycin A, also called Aclarubicin, combines dual topoisomerase inhibition with apoptosis and proteasome-related activity for layered cancer-cell assays. This guide translates that pharmacology into practical workflows for DNA damage, nucleolar stress, caspase signaling, and persistent lesion studies while separating validated findings from optimization starting points.
-
V5 Epitope Tag Peptide: Kinetics-Aware Workflows
2026-08-17
The V5 Epitope Tag Peptide supports more than routine protein detection: it can help researchers distinguish epitope accessibility, antibody specificity, and binding kinetics across assays. This guide connects the GKPIPNPLLGLDST peptide with practical Western blotting, immunoprecipitation, and single-molecule imaging decisions.
-
WM-8014: Timing Epigenetic Assays for Causality
2026-08-16
WM-8014 is a potent KAT6A inhibitor for separating immediate acetyltransferase dependence from delayed senescence phenotypes. This guide translates RESTRICT-seq concepts into practical assay design, controls, and interpretation for cancer biology research.
-
A-769662: Mechanism, Assays, and Metabolic Insight
2026-08-15
A-769662 is a reversible AMPK activator for dissecting energy metabolism, lipid synthesis, autophagy, and proteasome-linked phenotypes. This guide connects its pharmacology to modern assay design and explains why AMPK activation should not automatically be interpreted as autophagy induction.
-
Cyanidin Chloride: From Redox Control to Translation
2026-08-14
A translational framework for evaluating Cyanidin Chloride across radical-scavenging, inflammatory, and epithelial barrier models while distinguishing direct aglycone evidence from related glycoside findings.
-
Thioguanine: Mechanism-to-Assay Guide
2026-08-14
Thioguanine and 6-thioguanine connect purine metabolism with experimentally testable antitumor and antiviral phenotypes. This guide explains how to separate HGPRT, DNMT1-related, apoptosis, and viability signals when designing reproducible assays.
-
PID1, Oxysterols, and Antitumor Macrophage Reprogramming
2026-08-13
The reference study identifies PID1 as an immunometabolic regulator that suppresses LDL uptake and limits the generation of antitumor oxysterols in tumor-associated macrophages. Its findings connect PID1 loss to cholesterol accumulation, reactive oxygen species, 5α,6α-epoxycholesterol and 7β-hydroxycholesterol production, inhibition of mTOR–STAT6 signaling, and improved CD8+ T cell-mediated tumor control.
-
Sin3L/Rpd3L HDAC Activation by Inositol Phosphates
2026-08-12
Marcum and Radhakrishnan showed that inositol phosphates stimulate HDAC1/2 activity in the conserved Sin3L/Rpd3L complex through the SAP30 zinc finger, a mechanism functionally analogous to—but structurally distinct from—the SANT-domain mechanism found in other HDAC assemblies. Their biochemical, interaction, and NMR experiments also identified RBBP4 as a constitutive activity-enhancing subunit, separating inducible and baseline regulation within one complex.
-
A-769662: AMPK Activator Workflow Guide
2026-08-12
A-769662 provides reversible, direct AMPK activation for metabolic assays, while its proteasome-related activity demands careful dose and endpoint selection. This workflow guide connects fatty acid synthesis inhibition and type 2 diabetes research with a revised interpretation of AMPK, ULK1, and autophagy signaling.
-
Tropisetron Hydrochloride: Assay Workflows
2026-08-11
Tropisetron Hydrochloride supports both 5-HT3 receptor signaling experiments and transporter-focused renal secretion models. This guide translates its dual receptor profile into practical concentration-response, OCT2/MATE1, and troubleshooting workflows for reproducible neuroscience and pharmacology research.
-
Gly-Gly-Phe-Gly: Applied Linker Workflows
2026-08-11
Gly-Gly-Phe-Gly is a compact, flexible spacer for drug conjugation research, antibody-drug conjugate development, peptide engineering, and biomaterial construction. This workflow-driven guide explains how to handle the GGFG peptide, design coupling screens, verify conjugation, and troubleshoot common sources of variability.
-
PD 173074: FGFR1 Assay Workflows
2026-08-10
PD 173074 is a nanomolar-potent FGFR1 tool for separating FGF-2-dependent biology from signaling driven by other trophic factors. This workflow-focused guide covers neuronal assays, VEGFR2 inhibition, angiogenesis models, cancer research, and practical troubleshooting.